نتائج البحث

TLE3 Is a Novel Fusion Partner of JAK2 in Myeloid/Lymphoid Neoplasm With Eosinophilia Responding to JAK2 Inhibition

• Authors : Lazarevic, Vladimir; Lilljebjörn, Henrik; Olsson-Arvidsson, Linda ...

Subjects: Medical and Health Sciences; Basic Medicine; Medical Genetics and Genomics (including Gene Therapy)

• Source: Genes Chromosomes and Cancer. 63(8):1-8

تفاصيل العنوان

Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm

• Authors : National Cancer Institute (NCI); Mustang Bio, Inc.

• Source: Phase I Study of Cellular Immunotherapy Using T Cells Lentivirally Transduced to Express a CD123-Specific, Hinge-Optimized, CD28-Costimulatory Chimeric Antigen Receptor and a Truncated EGFR for

تفاصيل العنوان

Outcomes of laparoscopic single-incision caecal pole resection for low-grade appendiceal mucinous neoplasm.

• Authors : Kwak, Han Deok¹ (AUTHOR)

• Source: Journal of Minimal Access Surgery. Apr-Jun2025, Vol. 21 Issue 2, p107-111. 5p.

تفاصيل العنوان

Global trends and projections in the burden of malignant neoplasm of bone and articular cartilage

• Authors : Jialiu Fang; Xiaoyue Zhang; Rui Zhu

Subjects: Age-standardized rates; Estimated annual percentage change; Malignant neoplasm of bone and articular cartilage

• Source: Discover Public Health, Vol 22, Iss 1, Pp 1-13 (2025)

تفاصيل العنوان

Machine learning allows robust classification of lung neoplasm tissue using an electronic biopsy through minimally-invasive electrical impedance spectroscopy

• Authors : Georgina Company-Se; Virginia Pajares; Albert Rafecas-Codern

Subjects: Classification; Machine learning; Minimally-invasive bioimpedance

• Source: Scientific Reports, Vol 15, Iss 1, Pp 1-11 (2025)

تفاصيل العنوان

Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm

• Authors : National Cancer Institute (NCI)

• Source: Evaluation of Ruxolitinib and Azacytidine Combination as a Therapy for Patients With Myelofibrosis and Myelodysplastic Syndrome/ Myeloproliferative Neoplasm

تفاصيل العنوان

Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm

• Source: A Phase I/II Study of Azacitidine, Venetoclax, and Gilteritinib for Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome With an Activating FLT3 Mutation

تفاصيل العنوان

Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations

• Authors : National Cancer Institute (NCI)

• Source: Phase I/II Study of Azacitidine in Combination With Quizartinib for Patients With Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms With FLT3 or CBL Mutations

تفاصيل العنوان

Role of Frozen Section in Categorization of Thyroid Follicular Neoplasm

• Authors : Mohamed Hamdy Sayed, Demonstrator at Pathology Department In New Valley University

• Source: Role of Frozen Section in Categorization of Thyroid Follicular Neoplasm

تفاصيل العنوان

Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

• Authors : National Cancer Institute (NCI)

• Source: Phase 2 Clinical Trial for Comprehensive Treatment Program for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Tagraxofusp (SL-401) in Combination

تفاصيل العنوان